| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |